(Q37984096)

26 August 2017

title

Cryopyrin-associated periodic syndromes: diagnosis and management (English)

1 reference

cryopyrin-associated periodic syndrome

26 August 2017

main subject

1 reference

Takako Miyamae

1

1 reference

26 August 2017

publication date

1 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

14

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

109-117

1 reference

https://scigraph.springernature.com/pub.10.2165/11595040-000000000-00000

26 August 2017

exact match

0 references

cites work

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Analysis of cryopyrin-associated periodic syndromes (CAPS) in German children: epidemiological, clinical and genetic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signals

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

The inflammasome: first line of the immune response to cell stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Genetic and molecular basis of inflammasome-mediated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Neonatal onset multisystem inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

NOMID--a neonatal syndrome of multisystem inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Infantile-onset multisystem inflammatory disease: radiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Phenotype-genotype analysis of cryopyrin-associated periodic syndromes (CAPS): description of a rare non-exon 3 and a novel CIAS1 missense mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Natural history and outcome in systemic AA amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Effect of anakinra on arthropathy in CINCA/NOMID syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Interleukin-1-receptor antagonist in the Muckle-Wells syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Rilonacept--CAPS and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

Use of canakinumab in the cryopyrin-associated periodic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11595040-000000000-00000

TNFRSF1A-associated periodic syndrome (TRAPS), Muckle-Wells syndrome (MWS) and renal amyloidosis

21 January 2018

1 reference

12 December 2020

Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome

1 reference

12 December 2020

The rash of rheumatoid arthritis and Still's disease

1 reference

12 December 2020

A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy

1 reference

12 December 2020

10.2165/11595040-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1005005285

0 references

1 reference